Keyphrases
Radiation Therapy
49%
Breast Cancer
41%
Breast Reconstruction
39%
Accelerated Partial Breast Irradiation
30%
Breast Cancer Patients
27%
Breast
24%
Early Breast Cancer
23%
Radiotherapy
20%
Overall Survival
17%
Local Recurrence
16%
Ductal Carcinoma in Situ
14%
Radiation Oncology
14%
American Society
13%
Lumpectomy
12%
Mastectomy
12%
Ipsilateral Breast Tumor Recurrence
12%
Local Relapse
11%
Surgery Therapy
11%
Prognostic Significance
11%
Tumor
10%
Conservative Surgery
10%
Local Control
10%
Breast-conserving Therapy
10%
Breast Carcinoma
9%
Distant Metastasis
9%
ACR Appropriateness Criteria
9%
Chemotherapy
9%
MammoSite
8%
Registry Trial
7%
Breast Cancer Susceptibility Gene 1 (BRCA1)
7%
Breast Surgeon
7%
Confidence Interval
6%
Cosmesis
6%
Hypofractionation
6%
Whole Breast Radiotherapy
6%
Locoregional Recurrence
6%
Head-and-neck
6%
BRCA1, BRCA2
5%
Neoadjuvant Chemotherapy
5%
Human Epidermal Growth Factor Receptor 2 (HER2)
5%
Ductal Breast Carcinoma
5%
Meta-analysis
5%
Postmastectomy Radiation Therapy
5%
Breast Cancer Recurrence
5%
Patients with Breast Cancer
5%
Brachytherapy
5%
Hypofractionated Whole Breast Irradiation
5%
Tissue Microarray
5%
BRCA2
5%
Older Women
5%
Medicine and Dentistry
Breast Cancer
100%
Radiation Therapy
80%
Recurrent Disease
34%
Neoplasm
25%
Quadrantectomy
24%
Accelerated Partial Breast Irradiation
18%
Breast Radiotherapy
18%
Overall Survival
18%
Intraductal Carcinoma
17%
Diseases
16%
Mastectomy
15%
Breast Tumor
14%
Radiation Oncology
14%
Lumpectomy
13%
Tumor Recurrence
11%
BRCA1
11%
Breast-Conservation Therapy
11%
Brachytherapy
11%
Breast Carcinoma
11%
Surgeon
10%
Malignant Neoplasm
9%
Distant Metastasis
8%
Recurrence Risk
7%
Cosmesis
7%
BRCA2
7%
Estrogen Receptor
7%
Cosmetics
6%
Survival Rate
6%
Lymph Node
6%
Neoadjuvant Chemotherapy
6%
Protein P53
6%
Tissue Microarray
5%
Disease Free Survival
5%
Mammography
5%
Clinical Trial
5%
Cancer
5%
Meta-Analysis
5%
Adjuvant Therapy
5%
Recurrence Free Survival
5%
Axillary Lymph Node
5%
